Comparative clinical efficacy of alemtuzumab and ocrelizumab in patients with relapsing-remitting multiple sclerosis: Number needed to treat analyses

Affiliation auteurs!!!! Error affiliation !!!!
TitreComparative clinical efficacy of alemtuzumab and ocrelizumab in patients with relapsing-remitting multiple sclerosis: Number needed to treat analyses
Type de publicationJournal Article
Year of Publication2017
AuteursComi G., Boster A., Alroughani R., Berkovich R., Izquierdo G., Kantor D., Laganke C., Limmroth V., Macdonell R., Moreau T., Sharrack B., Wiendl H., van Wijmeersch B., Margolin D.H, Thangavelu K., Melanson M., Freedman M.S
JournalEUROPEAN JOURNAL OF NEUROLOGY
Volume24
Pagination492
Date PublishedJUL
Type of ArticleMeeting Abstract
ISSN1351-5101